Health23andMe has sold the rights to develop a drug based on its users’ DNA Consumer genomics firm 23andMe has signed its first deal to sell the rights to develop a new drug for inflammatory diseases to a pharmaceutical company News
HealthLyme disease in England and Wales is most common in older, white women An analysis of hospital records has found that people with Lyme disease in hospitals in England and Wales tend to be white, female and relatively affluent News